For PHD2, no differences were seen in inflamed biopsies from patients with UC, CD and infectious colitis versus non-inflamed biopsies from IBD patients in remission or healthy controls (Figure 1B). This evidence concerns the gene EGLN1 and inflammatory bowel disease.